15th ANNUAL
UCLA HUMAN GENE MEDICINE SYMPOSIUM
Engineering T Cells for Immunotherapy: The Clone Wars
Monday June 21, 2010 – 8:30 AM - 1:00 PM
23-105 Center for the Health Sciences, UCLA
8:30 AM
Continental breakfast available
9:00 – 9:10
Opening remarks
Donald B. Kohn, M.D.
Director, UCLA Gene Medicine Program
Professor, Depts. of MIMG and Pediatrics
David Geffen School of Medicine at UCLA
9:10 – 9:50
“Engineering Immunity Against Cancer and HIV”
Lili Yang, Ph.D.
Lead Scientist & Project Manager
Engineering Immunity Program
Laboratory of David Baltimore
Division of Biology
California Institute of Technology, Pasadena, CA
9:50 – 10:30
“TCR Engineering Adoptive Cell Transfer Therapy for Melanoma”
Antoni Ribas, M.D.
Associate Professor, Depts. of Medicine and Surgery
Associate Director, JCCC Tumor Immunology Program Area
David Geffen School of Medicine at UCLA
10:30 – 11:10
“NCI Clinical Experience Using Genetically Engineered T Cells for the
Treatment of Cancer”
Richard A. Morgan, Ph.D.
Staff Scientist, Surgery Branch
Center for Cancer Research
National Cancer Institute, National Institutes of Health, Bethesda, MD
11:10 – 11:30
Coffee break
11:30 – 12:10
“Engineering T Cell Immunity Via Stem Cells”
Jerome A. Zack, Ph.D.
Professor, Dept. of Medicine
Professor and Vice Chair, Dept. of MIMG
Director, UCLA Center for AIDS Research (CFAR)
David Geffen School of Medicine at UCLA
12:10 – 12:50
“Engineered T Cells: Is the Genie Finally Out of the Bottle?”
Carl H. June, M.D.
Professor, Dept. of Pathology and Laboratory Medicine
Director of Translational Research, Abramson Family Cancer Research Institute
University of Pennsylvania, Philadelphia, PA
1:00 PM
Adjourn
Sponsored by the UCLA Human Gene Medicine Program
Admission is free. No reservations are required. Seating is limited.
For further information contact: Dr. Sylvia Kiertscher, (310) 206-8318, skiertscher@mednet.ucla.edu